載入...
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
BACKGROUND: Oligonucleotide drug development has revolutionised the drug discovery field. Within this field, ‘small’ or ‘short’ activating RNAs (saRNA) are a more recently discovered category of short double-stranded RNA with clinical potential. saRNAs promote transcription from target loci, a pheno...
Na minha lista:
| 發表在: | Curr Pharm Biotechnol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Bentham Science Publishers
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6204661/ https://ncbi.nlm.nih.gov/pubmed/29886828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1389201019666180611093428 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|